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to MObjectives: The durability of valve-sparing aortic root replacement with or without cusp repair in patients with
bicuspid aortic valve (BAV) disease is questioned. We analyzed the results of 75 patients with a BAVundergoing
Tirone David reimplantation valve-sparing aortic root replacement.
Methods: Average age was 45  10 years; 80% were male; 31% had 2þ or greater aortic regurgitation (AR);
annular diameter averaged 28  3 mm; 32% had a Sievers’ type 0 BAV, and 66% underwent concomitant cusp
repair (usually cusp free margin shortening) to correct prolapse. Early (6  3 days) and late (2.9  1.7, 1-10
years) postoperative echocardiographic results were compared (cumulative echocardiographic follow-up, 190
patient-years; median late interval, 2 years [interquartile range, 0.68, 4.2]). Seven patients remained at risk be-
yond 6 years. Clinical outcome and valve function were analyzed using log–rank calculations.
Results: Actuarial survival was 99% 2%; freedom from reoperation was 90% 5%, infection 98% 2%,
and stroke 100% at 6 years. After initial improvement in degree of AR (P<.001), minor subclinical progression
of AR was observed (P>.5); however, freedom from AR of more than 2þ was 100%. Cusp free margin short-
ening was not associated with valve deterioration, but commissural suspensory polytetrafluoroethylene neo-
chord creation (n ¼ 4) portended a higher probability of recurrent AR (P ¼ .025).
Conclusions:After David procedure and cusp repair in patients with a BAV, midterm clinical and valve function
outcomes were favorable out to 6 years. More follow-up is required to determine long-term valve durability and
the hazard of other clinically important late adverse events, including eventual reoperation, to beyond 10 years.
(J Thorac Cardiovasc Surg 2013;145:S35-40)Supplemental material is available online.
Valve-sparing aortic root replacement (V-SARR) using the
David technique combined with cusp repair (CR) has been
proposed as a better treatment alternative than valve repair
alone or with aortic remodeling or reduction aortoplasty in
patients with a bicuspid aortic valve (BAV).1-10 Aortic
regurgitation (AR) in patients with BAV is commonly due
to a dilated, elliptically shaped aortic annulus (El Khoury
type I AR)3 or cusp diseases, for example, prolapse
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Aortic valve repair alone in patients with a malfunctioning
BAV is associated with suboptimal 10-year freedom from
reoperation11 in part because the aortic annular and root
geometric derangements remain uncorrected. Surgical re-
pair should frequently include concomitant replacement
or reconstruction of the dilated aortic root and correction
of annular dilatation in addition to CR to enhance the dura-
bility of the valve repair.4
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Panel 1 Kari et alS3Abbreviations and Acronyms
AR ¼ aortic regurgitation
BAV ¼ bicuspid aortic valve
CPB ¼ cardiopulmonary bypass
CR ¼ cusp repair
PTFE ¼ polytetrafluoroethylene
IQR ¼ interquartile range
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiogram
V-SARR ¼ valve-sparing aortic root
replacement
VS-MOD ¼ V–Stanford modification
Vmax ¼ maximal velocity6 The Joureported that valve repair alone is associated with accept-
able short-term and midterm results, including low rates
of thromboembolism, infection, and early mortality, with
acceptable rates of reoperation and freedom from recurrent
AR.11-13 More contemporary approaches recognize that the
annulus and aortic root should also be approached at the
time of initial valve repair, including aortic root
remodeling (Yacoub),8,12 subcommissural annuloplasty
(Cabrol stitch),6 or V-SARR using the David reimplantation
technique.6,9,10 Reports of outcome after Tirone David
V-SARR in combination with BAV repair, however, are
scant.6,10 Further, in the presence of a normal aortic root,
the wisdom of embarking on an aggressive V-SARR
approach to correct an isolated valve problem is
uncertain.2-4,10-12,14,15
We report midterm results in 75 patients with a BAV who
underwent Tirone David V-SARR I (2%) or Tirone David




Seventy-five patients with a BAV (normally functioning or regurgitant)
who underwent Tirone David V-SARR or VS-MOD, with or without con-
comitant CR, between 1997 and 2011 were included. See Table 1 for
patient characteristics. The distribution of Sievers’ BAV configuration
types,15 preoperative valve function, and BAV-associated aortopathy
(Fazel-Stanford clusters16) are summarized in Tables 2 and 3. Thirty
(39%) patients had no AR, 22 (29%) had 1þ AR, but 23 (31%) had 2þ
or more AR (8 had 4þ AR) (Table 2). See Appendix E1 for more details.
End Points
The primary end points were freedom from death and freedom from re-
operation owing to any cause. Intraoperative echocardiographic end points
were postrepair cusp coaptation height, grade of residual AR, mean and
peak aortic gradients, and maximal velocity (Vmax). Follow-up echocardio-
graphic end points were freedom from AR greater than 2þ, transvalvular
gradients, and Vmax.rnal of Thoracic and Cardiovascular SurgRESULTS
Annular Dimension Change
The median proximal graft size was 34 mm (range, 30-38
mm; interquartile range [IQR], 33-34 mm), which was
necked down over a valve sizer to a median annular external
diameter of 27 mm (range, 21-31 mm; IQR, 27-27 mm).
This reduced the annular dimension from 27.9  2.9 mm
preoperatively to 23.1  2.2 mm postoperatively
(P<.001). In 7 patients without preoperative annular dila-
tion, annular diameter was unchanged. For the other 68
(91%) patients the annulus was more than 5 mm smaller
in 39, more than 6 mm smaller in 26, and more than 7
mm smaller in 20. Annular size reduction was not associ-
ated with increased need for CR (number of free margin
shortening sutures, P>.05). Furthermore, annular dimen-
sion reduction over 5 mm did not have any significant im-
pact on recurrent AR by log–rank analysis (P > .05).
Patients who had annular dimension reduction exceeding
6 mm, however, were more likely to have AR greater than
2þ late postoperatively (P ¼ .02).
Survival
Themean follow-up interval was 3 years (range, 7 days to
9.2 years; 25th and 75th percentiles, 224 days and 1521
days, respectively). Cumulative follow-up was 190
patient-years. There was 1 early postoperative death owing
to right ventricular failure precipitated by injury to a small,
nondominant right coronary artery in a 20-year-old woman
after V-SARR and total arch replacement in 1997. No late
deaths have occurred to date, resulting in an actuarial sur-
vival estimate of 98%  2% at 3 months.
Reoperation
Freedom from any reoperation was 90%  5% at 2.8
years (3 events, only 2 of which were valve related,
Figure 1). See Appendix E1 for further details. Log–rank
tests showed no difference in freedom from reoperation be-
tween patients who had cusp free margin shortening com-
pared with those who did not (P ¼ .8). Similarly, there
was no difference in reoperation pivoting on BAV configu-
ration type (Sievers’ type 1 [S1, one raphe] vs Sievers’
type 0 [S0, no raphe, ‘‘naturally perfect’’], P ¼ .268).15
Endocarditis and Thromboembolism
There were no cases of endocarditis aside from the pa-
tient described (Appendix E1), who required reoperation.
Freedom from endocarditis was 98%  2% at 8 months.
There were no strokes or major systemic thromboembolic
complications, but 1 patient had a transient ischemic attack
late postoperatively without any permanent deficit.
Intraoperative Valve Hemodynamic Function
The aortic mean gradient was 7.6  3.3 mm Hg, peak
gradient was 13.6  6 mm Hg, and Vmax was 176.9  41ery c March 2013
TABLE 1. Baseline characteristics and procedure details for the 75
patients with bicuspid aortic valves undergoing David valve-sparing
aortic root replacement
Age, y, mean  SD (range) 45  10 (20-64)
Gender
Male, n (%) 60 (80)
Female, n (%) 15 (20)
Height, cm, mean  SD (range) 172  30 (155-198)
Weight, kg, mean  SD (range) 86  16 (56-135)
Marfan syndrome, n (%) 7 (9)
Loeys-Dietz syndrome, n (%) 0
Acute aortic dissection, n (%) 0
Left ventricular EF,%, mean  SD (range) 60  4 (50-70)
Aortic regurgitation (any), n (%) 46 (61)
Aortic root replacement 75 (100)
Tirone David I, n (%) 2 (3%)
Tirone David VS-MOD, n (%) 73 (97%)
Previous CV surgery, n (%) 4 (5)
Prior coarctation repair 4
Concomitant cardiac procedure, n (%) 2 (3)
Mitral valve repair 2
Transverse arch replacement, n (%) 48 (64)
Peninsula technique, partial 45
Peninsula technique, total 3
Cusp free margin repair, n (%) 50 (67)
 One cusp free margin shortening stitch 50
Triangular raphe resection 7 (9)
Commissural suspensory neochord creation (PTFE) 3 (4)
SD, Standard deviation; EF, ejection fraction; VS-MOD, V–Stanford modification;
CV, cardiovascular; PTFE, polytetrafluoroethylene (Gore-Tex; W. L. Gore & Associ-
ates, Inc, Flagstaff, Ariz).
Kari et al Panel 1cm/s preoperatively. Transesophageal echocardiography
(TEE) after weaning from cardiopulmonary bypass (CPB)
showed that the postrepair coaptation height achieved by
V-SARR reduction of annular size and CR was 9  0.9
mm. Two patients had 1þ (mild) AR; the other patients
had either no (74%) or trace (15%) AR. Post-CPB TEE
aortic valve mean gradient was 6.8 4.9 mm Hg, peak gra-
dient was 14.1  1.8 mm Hg, and Vmax averaged 180  60
cm/s (not significant vs preoperative condition for all).TABLE 2. Preoperative geometry, BAV configuration types according to Si




(n ¼ 17) (
AR, n (%) 45 (60) 7 (42)
El Khoury type I (annular dilation), n (%) 9 (12) 3 (18)
Annular diameter mm, mean  SD (range) 28  2.9 27.8  3.1 29
El Khoury type II (cusp prolapse), n (%) 45 (60) 10 (59)
No/trivial (0) AR, n (%) 30 (39) 10 (59)
Mild (1þ) AR, n (%) 22 (29) 4 (24)
Moderate (2þ) AR, n (%) 13 (17) 3 (18)
Moderate-severe (3þ) AR, n (%) 2 (3) 0
Severe (4þ) AR, n (%) 8 (12) 0
Median AR grade (IQR) 1(0-2) 0 (0-0)
Aortic stenosis (%) 0 0
BAV, Bicuspid aortic valve; ANOVA, analysis of variance; AR, aortic regurgitation; SD, sta
The Journal of Thoracic and CarEarly and Late Postoperative Valve Function
The median time of the early postoperative TTE was 5
days (IQR, 4-6 days; mean, 6  3 days; range, 3-19
days); for the latest echocardiographic assessment, the me-
dian time was 2.4 years (IQR, 1.6-4.2 years; mean, 3  1.9
years; range, 67-9.2 years). AR grade changed from a preop-
erative median of 1 (IQR, 0-2) to a median of 0 (IQR, 0) at
the time of the early TTE study (P<.001, Wilcoxon); mean
gradient (6.8  4.9 mm Hg vs 8.5 3.5 mm Hg), peak gra-
dient (14.1  8 mm Hg vs 15.1  5.3 mm Hg), and Vmax
(180  60 cm/s vs 194  44 cm/s) were unchanged.
At the time of the latest TTE follow-up examination, the
median AR grade was 0 (IQR, 0-1), unchanged compared
with the early postoperative TTE. The late postoperative
mean gradient was 12.1  5.6 mm Hg, peak gradient
22  11 mm Hg, and Vmax 229  56 cm/s, indicating no
increase in degree of aortic stenosis over time.
In 19 patients there was progression of AR over time
(Figure 2). Sixteen patients went from none to 1þ AR, 2
from none to 2þ, and 1 from 1þ to 2þ. By log–rank tests,
CR (P ¼ .358), number of free margin sutures placed
(P ¼ .373), cusp fibrosis or sclerosis (P ¼ .348), and Si-
evers’ BAV type (P ¼ .66) did not have any significant im-
pact on freedom from AR progression over time. AR as
a function of time is illustrated in Figure 2.
DISCUSSION
Decision-making in this experience was uniform with re-
spect to whether or not CR was performed. All underwent
V-SARR (98%, Tirone David VS-MOD).
14 In contrast, root
reconstruction techniques varied widely in other series,
and David V-SARR was used sparingly. Aicher and associ-
ates1 reported on 316 patients with a BAV who underwent
repair: one hundred had subannular plication, 122 root re-
modeling (David II), and 2 (0.6%) patients had aortic
root reimplantation. In 2005, Alsoufi and coworkers17 pub-
lished a series of 71 patients from Toronto who underwent










(n ¼ 0) P
4 (57) 33 (75) 1 (20) 0 — .008
1 (14) 4 (1) 1 (25) 0 — .571
.5  2.2 27.7  2.8 27.2  3.1 29  5.7 — .56
4 (57) 27 (61) 2 (40) 2 (100) — .821
3 (43) 11 (25) 4 (80) 2 (100) — .008
2 (29) 15 (34) 1 (20) 0 — .777
2 (29) 8 (18) 0 0 — .655
0 2 (5) 0 0 — .833
0 8 (18) 0 0 — .173
1 (0-2) 1 (1-2) 0 0 — .006
0 0 0 0 — —
ndard deviation; IQR, interquartile range.
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TABLE 3. Distribution of preoperative radiographic aneurysmal
disease according to Stanford-Fazel clusters of BAV-associated
aortopathy in 75 BAV patients based on CTA or MRA imaging
Cluster I (root only), n (%) 34 (45.3)
Intermediate cluster I-II (root þ Asc Ao), n (%) 19 (25)
Cluster II (normal root, Asc Ao, normal arch), n (%) 1 (1.3)
Cluster III (normal root, Asc Ao and Ao arch), n (%) 16 (21.3)
Cluster IV (root þ Asc Ao þ arch), n (%) 24 (32)
BAV, Bicuspid aortic valve; CTA, computed tomographic angiography; MRA, mag-
netic resonance angiography; Asc Ao, ascending aorta; Ao arch, aortic arch.
FIGURE 2. Preoperative, early postoperative, and late postoperative de-
grees of echocardiographic aortic regurgitation. See text for details of the
timing of the postoperative echocardiograms. n.s., Not significant.
Panel 1 Kari et alV-SARR (23%). The Mayo group11 repaired a regurgitant
BAV in 108 patients (average age, 41 years), but some
type of aortic graft or reduction aortoplasty was carried
out in only 21%, reflecting the isolated valve approach
that does not correct simultaneously annular and root path-
ologic conditions. This may explain why only 49% of
patients at 10 years were free from reoperation for AVR,
but follow-up was long (23 years, average follow-up time,
5.1  4.1 years).11 El Khoury’s unit4 in Brussels earlier re-
ported on 122 patients undergoing BAV repair, 34% of
whom underwent David V-SARR. Badiu and colleagues2
repaired BAV in 43 patients, but only 16 (37%) had aortic
root reimplantation. A comprehensive analysis of 161 pa-
tients with a BAV by de Kerchove and colleagues6 from
El Khoury’s unit recently compared the midterm results af-
ter either elective David V-SARR or lesser procedures in-
cluding Yacoub remodeling with Cabrol subcommissural
annuloplasty or no annuloplasty. The 2 groups were
matched for aortic root dimension and degree of AR. Sur-
vival was similar to beyond 5 years, but the rates of lateFIGURE 1. Kaplan Meier estimate of freedom from reoperation for 75
patients with bicuspid aortic valve undergoing valve-sparing aortic root re-
placement. Error bars indicate 1 standard error of the mean.
S38 The Journal of Thoracic and Cardiovascular Surgreoperation and recurrent AR were significantly lower in
the V-SARR group. These observations represent compel-
ling arguments favoring formal V-SARR in terms of valve
repair durability, even if the aortic root is normal.6 Similar
recommendations have been voiced by De Paulis.7
In our experience, 66% of patients required some sort of
CR, usually free margin shortening sutures. This parallels
the trends reported from Homburg (88% plication),1 Tor-
onto (62% plication),17 and the Mayo Clinic (94% com-
missural plication, with either raphe excision or plication
[since 2000]).11 In only 7 of our patients was plication com-
bined with triangular raphe resection, which differs from its
frequent use in other institutions and was the most common
technique in the Mayo experience.11 Scarring, fibrosis, and
calcification of the cusps were similar, for example, 35% in
our series versus 45% in the Mayo report.11 Inasmuch as
patient age could be a potential confounder, it is noteworthy
that these patient cohorts had mean ages of 41.5  13.2
years in Toronto17 41  13 years at Mayo,11 49  14 years
in Homburg,1 and 45  10 years in our current series.
We avoid triangular raphe resection or formal cusp plica-
tion whenever possible so as not to impair cusp mobility. If
the 2 fused cusps are thin, not excessively prolapsing, and
the raphe is not densely fibrotic or calcified, free margin
shortening is usually adequate. The echocardiographic re-
sults reported herein demonstrated no significant postoper-
ative increase of aortic stenosis.
Cusp patch repair (used in as many as 18% of patients in
a report from Brussels3) was not performed. It correlates
with higher reoperation rates and overall worse outcome,
with a hazard ratio of 7.6 for reoperation.3 None of the 75
patients with BAV had El Khoury type Id AR owing to per-
foration, which might necessitate a patch. At Stanford, bi-
cuspid valves with type Id AR with large perforations are
replaced. Further, we do not resort to subcommissural plica-
tion annuloplasty (Cabrol) in the management of the dilated
aortic annulus, as has been routinely done by others in theery c March 2013
Kari et al Panel 1past,3 because the David V-SARR corrects the dilated annu-
lus in a definitive and reliable fashion. Subcommissural ma-
neuvers predicted inferior late valve function and more
reoperations in the latest report from Sch€afers’s unit1 in
Homburg (hazard ratio, 2.07; univariable analysis only).
Boodhwani and associates4 (from El Khoury’s unit) in
2010 reported 8-year freedom from reoperation after repair
of BAV to be as high as 83%. Freedom from other adverse
events such as thromboembolism was 96% at 8 years.4 In
the most recent Brussels report6 for patients undergoing Da-
vid V-SARR, the freedom from reoperation and recurrent
2þ AR or greater estimates were 100% at 5 years, similar
to our observations. Our findings add to a growing body
of evidence that the most definitive and reliable approach
to repair a regurgitant BAV is David V-SARR, even if the
aortic root is normal. In experienced centers, the early
risk is no higher than that associated with lesser procedures,
but the midterm results are superior.
Excessive cusp plication induces the potential danger of
creating aortic stenosis acutely by impairing cusp mobility
or over the long term by inducing fibrotic cusp remodeling.6
Reducing cusp mobility may also lead to recurrent or pro-
gressive AR.6 In our experience, free margin shortening
did not reduce cusp area or abolish mobility; the number
of free margin shortening stitches did not correlate with
AR progression. On the basis of our results primarily using
free margin shortening, we suggest that formal full cusp pli-
cation should be performed only rarely. If the fused cusps
are prolapsing markedly and upward of 1 cm of tissue re-
dundancy is present or the cusp free margin at the raphe
is fibrotic, then a small triangular raphe resection is
reasonable.
Hanke and colleagues18 carried out an elegant statistical
analysis of factors that portend more AR progression after
V-SARR in 84 patients. They identified cusp plication as
a predictor of progressive AR. Conversely, the only inde-
pendent predictor of AR progression that we identified
was creation of neosuspensory chords using polytetra-
fluoroethylene (PTFE) sutures (Gore-Tex; W. L. Gore &
Associates, Inc, Flagstaff, Ariz), which we have abandoned.
These primitive BAVs mimic quadricuspid truncal valves
and today are replaced at Stanford unless compelling indi-
cations are present that militate against AVR.
Fixation and especially downsizing of the annulus using
David V-SARR is one of the most important benefits when
treating patients with a BAV who have dilated and/or ellip-
tical annuli. We found that reduction by more than 6 mm
might be linked to more postoperative AR (higher rates of
AR>1þ). Inasmuch as overall there were only 3 patients
with AR 2þ and freedom from AR greater than 2þ was
100%, this caveat must be interpreted cautiously. This find-
ing needs to be validated in large cohort studies.
Overall, there was a slight trend toward progression of
AR with a median freedom from AR progression of 4.5The Journal of Thoracic and Caryears. Most of the patients, however, went from 0 to 1þ
AR at the 6- to 12-month TEE examination and stabilized
thereafter. Whether this translates into more severe AR and
more obligatory reoperations in the future remains un-
known, but we realistically do not expect these BAVs to
function satisfactorily as long as trileaflet aortic valves af-
ter V-SARR. Preoperatively, the patients must accept that
they are trading the avoidance of anticoagulation for
a low, but finite, risk of reoperation within 10 to 30 years.
This is why we do not favor sparing the BAV in older pa-
tients who are in their 60s inasmuch as progression of aor-
tic stenosis is unpredictable and they have fewer years to
benefit from avoiding anticoagulation. Alternatively, re-
placing a BAV in a patient in his or her late 50s or 60s
with a bioprosthetic valve graft (or ‘‘Bio-root’’) is attrac-
tive despite the relative young age because the substitute
bioprosthesis will constitute a more favorable landing
zone than the native BAV for possible transcatheter valve
replacement.
Given the favorable midterm outcomes in our experience
and the results of other experienced aortic centers,4,6,7,10
reconstructive approaches incorporating David V-SARR
are justified for many selected patients who have
a regurgitant or normally functioning BAV with or
without associated aortic root aneurysmal disease. The
introduction of repair-oriented terminology systems to de-
scribe the mechanism of AR by Boodhwani and colleagues3
from El Khoury’s group and a more refined understanding
of the mechanisms causing AR19 have improved reparative
techniques for bicuspid valves. A key decision is to aban-
don preservation of a bicuspid valve where the cusps are fi-
brotic, calcified, attenuated, and/or fenestrated, or
otherwise pathologically damaged, as such will lead to sub-
optimal results; these valves should be replaced. Compari-
son of various BAV repair techniques and strategies for the
aortic root in prospective randomized trials has not and re-
alistically will probably never be carried out. Long-term
outcomes beyond 10 years remain unknown. Adverse
events will continue to occur as these young patients age,
mandating caution and exceedingly careful patient selec-
tion at this point until 10- to 20-year surgical results become
available.
Limitations
In this series of V-SARR for BAV disease, few patients
remained at risk beyond 5 years. The ‘‘critical’’ (10% of
initial sample size) number of patients remaining at risk
was at 7 years. Our results should thus be considered mid-
term only.
This was a retrospective study, although most of the clin-
ical and valvular parameters were collected prospectively.
Annular diameters were documented prospectively during
the operation but validated retrospectively by computed
tomographic angiography measurements.diovascular Surgery c Volume 145, Number 3S S39
Panel 1 Kari et alOverall, the small number of adverse events precluded
using a hazard model to identify patient- or disease-
related variables predicting less salutary outcomes. Our
log–rank significant findings for rare end points such as
AR grade greater than 1þ must therefore be interpreted
with caution. Specifically, we found that reduction of the
annulus by more than 5 mm might be linked to more AR
(higher rates of AR>1þ). With only 3 patients having an
AR of 2þ and freedom from AR greater than 2þ being
100%, this link must be considered preliminary.
Clinically important events (stroke, hemorrhagic events,
infection, structural valve deterioration, reoperation) hap-
pen rarely and late postoperatively, which highlights the
need of future long-term investigations of V-SARR for pa-
tients with BAV disease. Randomized, prospective studies
would be prohibitively expensive and probably unrealistic.
Thus, we must rely on retrospective observations: the statis-
tical power of retrospective studies can be increased in the
future by performing large meta-analyses.
This experience included selected young patients with
BAVundergoing elective, first-time V-SARR, with probable
patient-referral and patient-selection biases. One surgeon
(D.C.M.) operated on all patients, making generalization
of the results to other surgeons or institutions speculative.
We acknowledge Michael Sheehan, MSN, RNFA, NPc for his
efforts in following up patients and capturing the late echocardio-
graphic images.
References
1. Aicher D, Kunihara T, Abou Issa O, Brittner B, Graber S, Schafers HJ. Valve con-
figuration determines long-term results after repair of the bicuspid aortic valve.
Circulation. 2011;123:178-85.
2. Badiu CC, Bleiziffer S, Eichinger WB, Zaimova I, Hutter A, Mazzitelli D, et al.
Are bicuspid aortic valves a limitation for aortic valve repair? Eur J Cardio-
thorac Surg. 2011;40:1097-104.
3. Boodhwani M, de Kerchove L, Glineur D, Poncelet A, Rubay J, Astarci P,
et al. Repair-oriented classification of aortic insufficiency: impact on surgical
techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009;137:
286-94.S40 The Journal of Thoracic and Cardiovascular Surg4. Boodhwani M, de Kerchove L, Glineur D, Rubay J, Vanoverschelde JL,
Noirhomme P, et al. Repair of regurgitant bicuspid aortic valves: a systematic
approach. J Thorac Cardiovasc Surg. 2010;140:276-84.e1.
5. Boodhwani M, El Khoury G. Principles of aortic valve repair. J Thorac Cardio-
vasc Surg. 2010;140(6 Suppl):S20-2; discussion S45-51.
6. de Kerchove L, Boodhwani M, Glineur D, Vandyck M, Vanoverschelde JL,
Noirhomme P, et al. Valve-sparing root replacement with the reimplantation
technique to increase the durability of bicuspid aortic valve repair. J Thorac
Cardiovasc Surg. 2011;142:1430-8.
7. De Paulis R. Aortic root surgery: from valve sparing to ‘spare and plasty.’ Eur J
Cardiothorac Surg. 2010;38:513-4.
8. DossM, Risteski P, Sirat S, Bakhtiary F,Martens S,Moritz A. Aortic root stability
in bicuspid aortic valve disease: patch augmentation plus reduction aortoplasty
versus modified David type repair. Eur J Cardiothorac Surg. 2010;38:523-7.
9. Svensson LG, Batizy LH, Blackstone EH, Gillinov AM, Moon MC,
D’Agostino RS, et al. Results of matching valve and root repair to aortic valve
and root pathology. J Thorac Cardiovasc Surg. 2011;142:1491-8.e7.
10. Svensson LG, Kim KH, Blackstone EH, Rajeswaran J, Gillinov AM,
Mihaljevic T, et al. Bicuspid aortic valve surgery with proactive ascending aorta
repair. J Thorac Cardiovasc Surg. 2011;142:622-9, 9 e1-3.
11. Ashikhmina E, Sundt TM 3rd, Dearani JA, Connolly HM, Li Z, Schaff HV.
Repair of the bicuspid aortic valve: a viable alternative to replacement with
a bioprosthesis. J Thorac Cardiovasc Surg. 2010;139:1395-401.
12. Aicher D, Fries R, Rodionycheva S, Schmidt K, Langer F, Schafers HJ. Aortic
valve repair leads to a low incidence of valve-related complications. Eur J Car-
diothorac Surg. 2010;37:127-32.
13. Pettersson GB, Crucean AC, Savage R, Halley CM, Grimm RA, Sevensson LG,
et al. Toward predictable repair of regurgitant aortic valves—a systematic
morphology-directed approach to bicommissural repair. J Am Coll Cardiol.
2008;52:40-9.
14. Demers P, Miller DC. Simple modification of ‘‘T. David-V’’ valve-sparing aortic
root replacement to create graft pseudosinuses. Ann Thorac Surg. 2004;78:
1479-81.
15. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve
from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226-33.
16. Fazel SS, Mallidi HR, Lee RS, Sheehan MP, Liang D, Fleischman D, et al. The
aortopathy of bicuspid aortic valve disease has distinctive patterns and usually
involves the transverse aortic arch. J Thorac Cardiovasc Surg. 2008;135:
901-7, 7 e1-2.
17. Alsoufi B, Borger MA, Armstrong S, Maganti M, David TE. Results of valve
preservation and repair for bicuspid aortic valve insufficiency. J Heart Valve
Dis. 2005;14:752-8; discussion 8-9.
18. Hanke T, Charitos EI, Stierle U, Robinson D, Gorski A, Sievers HH, et al. Factors
associated with the development of aortic valve regurgitation over time after two
different techniques of valve-sparing aortic root surgery. J Thorac Cardiovasc
Surg. 2009;137:314-9.
19. Augoustides JG, SzetoWY, Bavaria JE. Advances in aortic valve repair: focus on
functional approach, clinical outcomes, and central role of echocardiography.
J Cardiothorac Vasc Anesth. 2010;24:1016-20.ery c March 2013
APPENDIX E1
Methods
Operative techniques. If transverse arch replacement was carried
out, CPB arterial cannulation usually used a 6- to 8-mm Dacron graft su-
tured to the innominate artery for CPB and selective antegrade cerebral per-
fusion. The original Feindel-David formula (graft diameter z [average
cusp height $ 2 $ 0.67] þ 2 aortic wall thickness) determined the nominal
size of the proximal graft, but recently we have used larger graft sizes. The
Stanford modification of the Tirone David-V V-SARR technique is de-
scribed elsewhere.14
Four patients without any cusp prolapse initially had some degree of
prolapse after a root replacement procedure requiring free margin repair.
CR procedures included placement of 5-0 or 6-0 PTFE or braided polyester
sutures at the nodulus of Arantius and/or peripherally to shorten the cusp
free margin, triangular raphe resection, suspensory neocord creation with
4-0 or 5-0 PTFE suture, or combinations of these techniques, as illustrated
in Figure E1. Formal cusp plication from the free margin to the cusp hinge
was not used. Figure E2 shows the different CR techniques subdivided ac-
cording to type of BAV and cusp location.
Data assessment and statistical analysis. Informed consent
was obtained; the Stanford University Institutional Review Board approved
this study. Details of valve configuration, specifics of location and severity
of prolapsing cusps, and details of specific CRs were retrospectively ex-
tracted from operative reports. The pathologic BAV cusp configuration ac-
cording to Sievers’ types was confirmed and cusp lesions such as
thickening, fibrosis, or calcification were noted intraoperatively. Localiza-
tion and severity of cusp prolapse was documented. After valve reimplan-
tation into the proximal graft, cusp coaptation height and prolapse were
again assessed to determine whether cusp free margin shortening was
necessary.
Intraoperative TEE before and after root reimplantation was used to
measure gradients, Vmax, cusp coaptation heights, and residual AR. All
patients had a predischarge transthoracic echocardiogram (TTE) early
postoperatively; annual TTE was recommended thereafter, but not univer-
sally carried out. Late postoperative echocardiographic images were
obtained whenever possible from outside institutions and analyzed by an
experienced echocardiographer (D.H.L.). Annular dimensions were de-
rived from preoperative and postoperative echocardiography or computed
tomographic scans. If the annulus was oblong, the minor and major axes
were averaged for analysis.
Kaplan-Meier actuarial estimates (expressed as1 standard error of the
mean) and log–rank tests were calculated for comparative survival analysis
with respect to primary end points and echocardiographic valve function.
Student t tests and Wilcoxon tests were used for comparison of pretreat-
ment and posttreatment variables. Normality tests were performed for iden-
tification of data distribution. Continuous data are reported as mean 1
standard deviation or 95% confidence limits or as median plus IQRs
(25th and 75th percentiles). SigmaPlot and SigmaStat 11.0 (Systat Soft-
ware, San Jose, Calif), as well as SPSS 19 (IBM North America, New
York, NY), were used for analysis. Cox univariable and multivariable pro-
portional hazard analysis was attempted focusing on a composite end point
(>2þ AR, reoperation, or death), but the model was unstable owing to too
few events.
Results—Three Cases of Reoperation
One 46-year-old patient had fulminant prosthetic endocarditis, 4þ AR,
dehiscence of the left ventricular outflow tract between the right and non-
coronary sinuses, and destruction of the valve cusps 1 year postoperatively.
The infected valve and graft were replaced with a homograft root, supple-
mented by Kay-Zubiate procedures (short interposition saphenous vein
grafts to reconstruct the left and right main coronary ostia). Another patient
underwent mechanical valve replacement inside the Dacron graft 3 years
after the initial procedure owing to sudden recurrence of 4þ AR and left
ventricular dilatation. The original valve repair for severe AR had included
PTFE suture neochord reconstruction of ruptured commissural suspensory
chords, similar to those seen in truncal semilunar valves; the PTFE sutures
had dehisced, allowing the fused left and right cusps to become flail. The
third patient was a 48-year-old man who required a pericardectomy for
symptoms of pericardial constriction 2 years after TD-VS-MOD, total arch
replacement, and atrial septal defect repair.
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FIGURE E2. Types of cusp repair strategies performed at the time of re-
implantation of the valve-sparing aortic root replacement stratified accord-
ing to Sievers’ types of bicuspid aortic valve configuration. FM, Cusp free
margin; NC, noncoronary cusp; LC, left coronary cusp; RC, right coronary
cusp.
FIGURE E1. Upper images: Central free margin shortening on the fused
right and left coronary cusps (Sievers’ type S1/L-R configuration bicuspid
aortic valve [BAV]). Left, There is minimal cusp fibrosis or calcification and
aortic regurgitation (AR) is mainly caused by cusp redundancy and prolapse
(El Khoury type Ib AR). Right, Correction for prolapse to optimize coap-
tation level and height after placement of 2 central free margin shortening
sutures. Middle images, Sievers’ type S1/L-R BAV before (left) and after
(right) triangular resection of the raphe between the fused left and right
coronary cusps. Lower images: Left, Native suspensory cord to raphe
free margin between the fused right and left coronary cusps in a Sievers’
type S1/L-RBAVwith considerable thickening and fibrosis of raphe. Right,
Valve after neosuspensory-cord-creation using polytetrafluoroethylene
(PTFE) sutures to the prolapsing left-right fused cusp free margin at the
raphe and central free margin shortening of the noncoronary cusp.
Panel 1 Kari et al
S40.e2 The Journal of Thoracic and Cardiovascular Surgery c March 2013
